AMGN
AMGEN INC
NASDAQ · Healthcare · Drug Manufacturers - General · US
$424.94
−1.75%Forward multiples
Based on analyst estimates
- P/E forward
- 17.61x
- P/E 2026E
- 18.54x
- P/E 2027E
- 17.42x
- P/E 2028E
- 16.49x
- P/S forward
- 5.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.20x
- PEG TTM
- 0.54x
- Price / book
- 19.66x
- Price / sales
- 6.03x
- Price / cash flow
- 18.41x
Enterprise value
- Enterprise value
- $273.1B
- EV / sales
- 7.16x
- EV / EBITDA
- 15.49x
- EV / EBIT
- 21.59x
- Market cap
- $229.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026